A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy;Estudio abierto aleatorio y comparativo de la monoterapia con topiramato frente a carbamacepina en el tratamiento de pacientes pediátricos con epilepsia de reciente diagnóstico

Revista de Neurologia

Volumn 39, Issue 3, 2004, Pages 201-204

  Reséndiz Aparicio, Juan Carlos ^a   Rodriguez Rodriguez E ^a   Contreras Bernal, J ^b   Ceja Moreno, H ^c   Barragan Perez E ^d   Garza Morales, S ^d   Malagon Valdes J ^e   Ortega Gonzalez F ^f  

^a Hospital Psiquiatrico Infantil Dr Juan N Navarro   (Mexico)

^b Hospital del Niño de Toluca   (Mexico)

^c HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e Clin Atencion Neurodesarrollo   (Mexico)

^f Hospital Aranda de la Parra   (Mexico)

Author keywords

Antiepileptic drugs; Monotherapy; Newly diagnosed epilepsy; Seizures; Topiramate

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; SIDE EFFECT; SOMNOLENCE; WEIGHT REDUCTION;

EID: 4744356925     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3903.2004186     Document Type: Article

References (11)

1. Cockrell OC, Johnson AL, Sander JW, Hart YM, Shorvon SO. Remission of epilepsy: results from the national general practice study of epilepsy. Lancet 1995; 348: 140-4.
2. Marson AG, Chadwick DW. Comparing antiepileptic drugs. Clin Opin Neurol 1996; 9: 103-6.
3. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145-51.
4. Marson AG, Zadir ZA, Chadwick DW. New antiepileptic drugs: a systemic review of their efficacy and tolerability. Br Med J 1996; 313: 1169-74.
5. Tassinari CA, Michelucci R, Chauvel P, Chodiewicz J, Shorvon S, Henrikesen O, et al. Double-blind placebo controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996; 37: 763-8.
6. Ben-Menachem R, Henriksen O, Dam M, Schmidt D. Double-blind placebo controlled trial of topiramate as add-on treatment in patients with refractory partial epilepsy. Epilepsia 1996; 36: 539-43.
7. Faught E, Wilder BJ, Ramsay E, Reife R, Kramer L, Pledger G, et al. Topiramate controlled dose ranging trial in refractory partial epilepsy using 200, 400 y 600 mg daily dosages. Neurology 1996; 46: 1684-90.
8. Privitera M, Fincham R, Renry J, Reife R, Kramer K, Pledger G, et al. Topiramate placebo controlled trial in refractory partial epilepsy using 600, 800 and 1,000 mg daily dosages. Neurology 1996; 46: 1678-83.
9. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999; 52: 1338-44.
10. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999; 52: 1882-7.
11. Cavazos JE, Lum F, Spitz M. Seizures and epilepsy. Overview and classification. Br Med J 2002; 318: 1106-10.